Received tentative approval from the FDA for YUTREPIATM (treprostinil) inhalation powder for both pulmonary arterial hypertension (PAH) ...

The study demonstrates that activating the vitamin D receptor (VDR) with calcitriol suppresses cell proliferation in ...

Brilaroxazine is generally well tolerated to date in patients with acute and stable schizophrenia – – Topline data from 1-year open-label extension (OLE) trial now expected in December 2024 – ...

Authors of a recent review shared expert insights and tips for conducting cardiac catheterization procedures to diagnose ...

In patients with PAH, reducing peripheral serotonin using rodatristat ethyl negatively affects pulmonary hemodynamics and cardiac function.

The following is a summary of “Safety and efficacy of rodatristat ethyl for the treatment of pulmonary arterial hypertension (ELEVATE-2): a dose-ranging, randomised, multicentre, phase 2b trial,” ...

The propofol-ketamine combination significantly reduced the incidence of sedation-induced atelectasis and allowed faster emergence from anesthesia than propofol alone in children undergoing MRI.

Maria L. Padilla, MD, Icahn School of Medicine at Mount Sinai, previews that experts will discuss critical management strategies for interstitial lung disease and idiopathic pulmonary fibrosis, ...

Each year, 500 to 1,000 people in the United States are diagnosed with pulmonary arterial hypertension (PAH). Because this progressive, chronic disorder is rare, it is often under-detected, causing ...

The Pulmonary Hypertension Association (PHA) is fundraising and advocating this awareness month with a "Let Your Light Shine" ...

Not to be confused with the theme park attraction Disney's Hollywood Studios. Eisner, Disney's then-chief, intended Hollywood Pictures to be a full-fledged studio, like Touchstone, but in its later ...